The alleged use of misbranded dialysis drugs led to charges for a Kingsport, Tennessee pharmacist on Monday.
He's accused of substituting a cheaper drug from China for an FDA-approved drug for kidney dialysis patients.
U.S. Attorney Barry Grissom tells News 5 53-year-old Robert Harshbarger, Jr., doing business as American Inhalation Medication Specialists, Incorporated, is charged with one count of selling misbranded drugs, one count of mail fraud, and five counts of healthcare fraud.
We've learned the indictment alleges that Harshbarger's company, based in Kingsport, Tennessee, received more than $875,000 from Kansas Dialysis and more than $845,000 from Healthcare Benefit Programs, including Medicare and Medicaid for misbranded iron sucrose sold from 2004 to 2009.
Grissom says both current and past patients should not be concerned at this time.